American Society of Transplantation Cutting Edge of Transplantation 2026

Description

+ Include:  videos + file sub vtt +  pdf, size:  GB

+ Target Audience: Transplant Surgeons, Nephrologists, Hepatologists, Pulmonologists, Cardiologists, Immunologists, and Clinical Researchers

+ Sample video: contact me for sample video

+ Information:

The Cutting Edge of Transplantation (CEoT) 2026 is an innovation-driven, interactive meeting scheduled for February 26–28, 2026, in Scottsdale. Launched in 2013 and now in its 14th year, CEoT serves as the American Society of Transplantation’s focused, high-impact winter meeting. The event intentionally maintains a small footprint with fewer concurrent sessions to foster cross-disciplinary discussions, engage attendees, and facilitate meaningful connections among transplant clinicians, researchers, and leaders. By emphasizing modernization, equity, policy, and lifelong patient care, CEoT addresses current challenges—such as the HRSA OPTN Modernization Initiative and research funding cuts—to disseminate cutting-edge ideas that advance healthcare delivery.

Learning Objectives

• Evaluate current challenges and opportunities to improve patient care and expand clinical and research impact within the organ transplant ecosystem.

• Deepen understanding of advances in clinical transplantation across chronic and end-stage organ diseases.

• Assess novel endpoints, biomarkers, and registry data to accelerate drug labeling and development.

• Analyze ethical, regulatory, and practical considerations in xenotransplantation and deceased donor management research.

• Examine the current state and future of allocation algorithms, expedited systems, and continuous distribution for heart, kidney, liver, and lung transplantation.

• Formulate strategies to overcome health disparities, redesign continuity of care, and improve long-term graft survival outcomes.

Target Audience

CEoT brings together clinical and translational experts from the fields of chronic disease, end-stage organ disease, and solid organ transplantation. With fewer concurrent sessions and more shared time, CEoT makes it easy to build meaningful connections with transplant clinicians, researchers, and leaders shaping the field. This interactive forum is designed for participation, fostering cross-disciplinary discussions that drive new ideas and practical solutions in transplant care.

Best for Transplant Surgeons, Nephrologists, Hepatologists, Pulmonologists, Cardiologists, Immunologists, and Clinical Researchers.

Topics

• Keynote Speaker: Health Disparities Science and Transplantation

• Session 1: Navigating Shifting HHS and NIH Priorities: Opportunities and Strategic Responses for Transplantation (Opening Patient Perspectives & Panel Discussion)

• Session 2: Designing the Future of Transplantation through Innovative Clinical Research

• Session 2: Harnessing Biomarkers to Redefine Speed and Precision in Drug Development

• Session 2: Novel Endpoints to Spur Innovation in Transplantation

• Session 2: Registry Data to Expand and Accelerate Drug Labeling

• Session 3: Balancing Ethics with Innovation: The Frontier of Deceased Donor Management Research

• Session 3: Deceased Donor Research to Increase Organ Utilization and Improve Outcomes

• Session 3: Genomics Research Using Deceased Donor Tissue to Understand Normal and Abnormal DNA/RNA

• Session 3: Interventions in Recovery and Preservation of Deceased Donor Lungs

• Session 3: Regulatory and Ethical Challenges Related to Donor Research

• Session 4: Anti-Porcine Immunity and Rejection Mechanisms

• Session 4: Ethical Considerations and Public Trust Allotransplant Panel Discussion

• Session 4: Xeno Clinical Trial Readiness

• Session 4: Xeno In Practice: What the Future Will Look Like in Xeno

• Session 5 Opening Talk: Matching Algorithms

• Session 5: Heart Breakout (Continuous Distribution; Current State and Policies; Transport Devices; Pediatric Focus)

• Session 5: Kidney Breakout (Allocation of Scarce Resources; Continuous Distribution; Expedited Allocation Systems)

• Session 5: Liver Breakout (Continuous Distribution; Cost Efficient Strategies and Implementation of Perfusion Technologies; Out of Sequence Allocation)

• Session 5: Lung Breakout (Future Directions into 2035; OPO Perspective Challenges; Transplant Center Perspective Challenges)

• Session 6 Opening Talk: The Future of Transplant Expanding Possibilities for Patients

• Session 6: Heart Breakout (Replacing Transplant Need; Accelerating Development; Reaching the Underserved; Roadblocks to Candidacy)

• Session 6: Kidney Breakout (Expanding Access for Highly Sensitized Patients; Islet Cell Therapies for Diabetes; Access for Patients with a History of Cancer)

• Session 6: Liver Breakout (Adult Hepatologist Perspective; Pediatric Perspective in a Genomic Era; Transplant Surgeon/Surgical Director Perspective into 2035)

• Session 6: Lung Breakout (Emerging Infections in 2035; New Frontiers in ILD Therapy; Shifting Referral Patterns to Promote Equity; Expanding Eligibility for 2035)

• Session 7: Bridging the Gap: Redesigning Continuity of Care for Lifelong Transplant Success

• Session 7: From Treatment Burden to Treatment Freedom: Reimagining the Patient Experience

• Session 7: One Transplant for Life: Reimagining Long-Term Outcomes

• Session 7: The 10-Year Wall: Why Graft Survival Is Stalling

• Session 7: The Missing Link: Adjunct Therapies to Protect the Graft and the Patient